Response to Comment on Rosenstock et al. Impact of a Weekly Glucagon-Like Peptide 1 Receptor Agonist, Albiglutide, on Glycemic Control and on Reducing Prandial Insulin Use in Type 2 Diabetes Inadequately Controlled on Multiple Insulin Therapy: A Randomized Trial. Diabetes Care 2020;43:2509–2518
2016 ◽
Vol 18
(3)
◽
pp. 281-288
◽
2017 ◽
Vol 19
(7)
◽
pp. 1024-1031
◽
Keyword(s):
2017 ◽
Vol 9
(2)
◽
pp. 332-340
◽
2010 ◽
Vol 2
◽
pp. CMT.S4148
◽
2017 ◽
Vol 129
(4)
◽
pp. 436-445
◽